Literature DB >> 2105096

The influence of dexamethasone on growth hormone (GH). Response to GH-releasing hormone in normal men.

R Rupprecht1, A Niehaus, K P Lesch.   

Abstract

There is evidence that glucocorticoids may have a bimodal effect on growth hormone release in vitro and in vivo. To explore the influence of a single low dose administration of dexamethasone on the hypothalamic-pituitary-somatotropic system, 11 male healthy subjects received 50 micrograms synthetic human GHRH-44 amide as an i.v. bolus dose with and without pretreatment with orally administered 1 mg dexamethasone 9 hours prior to GHRH stimulation. Dexamethasone preparation did affect neither baseline levels of GH and IGF-I nor GHRH induced GH secretory patterns assessed by delta max and by the net area under the response curves. These results add to previous reports that corticosteroids may have different effects on GH secretory dynamics dependent on dose and duration of application.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105096     DOI: 10.1007/bf01251000

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  25 in total

1.  Glucocorticoid modulation of growth hormone secretion in vitro. Evidence for a biphasic effect on GH-releasing hormone mediated release.

Authors:  G P Ceda; R G Davis; A R Hoffman
Journal:  Acta Endocrinol (Copenh)       Date:  1987-04

2.  Triiodothyronine, thyroxine, and TSH response to dexamethasone in depressed patients and normal controls.

Authors:  R Rupprecht; C Rupprecht; M Rupprecht; M Noder; J Mahlstedt
Journal:  Biol Psychiatry       Date:  1989-01       Impact factor: 13.382

3.  Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.

Authors:  M Losa; J Schopohl; A König; O A Müller; K von Werder
Journal:  J Clin Endocrinol Metab       Date:  1986-08       Impact factor: 5.958

4.  Suppressibility of plasma growth hormone levels in acromegaly with dexamethasone and phentolamine.

Authors:  K Nakagawa; K Mashimo
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

5.  Suppression of the hypothalamo-pituitary-adrenal axis and growth hormone release with dexamethasone.

Authors:  K von Werder; S Hane; P H Forsham
Journal:  Horm Metab Res       Date:  1971-05       Impact factor: 2.936

6.  Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro.

Authors:  W Vale; J Vaughan; G Yamamoto; J Spiess; J Rivier
Journal:  Endocrinology       Date:  1983-04       Impact factor: 4.736

7.  The development of a direct homologous radioimmunoassay for serum cortisol.

Authors:  G K Stalla; G Giesemann; O A Müller; W G Wood; P C Scriba
Journal:  J Clin Chem Clin Biochem       Date:  1981-07

8.  Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness.

Authors:  O M Wolkowitz; D R Rubinow; A Breier; A R Doran; C Davis; D Pickar
Journal:  Life Sci       Date:  1987-10-19       Impact factor: 5.037

9.  Glucocorticoid effects on somatomedins and somatomedin inhibitors.

Authors:  T G Unterman; L S Phillips
Journal:  J Clin Endocrinol Metab       Date:  1985-10       Impact factor: 5.958

10.  Effects of glucocorticoids on the regulation of the hypothalamic-pituitary-somatotropic system in depression.

Authors:  R Rupprecht; C Rupprecht; M Rupprecht; M Noder; K P Lesch; J Mössner
Journal:  J Affect Disord       Date:  1989 Jul-Aug       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.